Acuitas Investments, LLC Passage Bio, Inc. Transaction History

Acuitas Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$0.79 - $1.58 $1,979 - $3,959	2,506 Added 0.53%	471,812 $372,000
Q1 2024 May 10, 2024	BUY	$0.86 - $1.73 $44,351 - $89,219	51,572 Added 12.35%	469,306 $633,000
Q4 2023 Feb 02, 2024	SELL	$0.6 - $1.01 $256 - $431	-427 Reduced 0.1%	417,734 $421,000
Q3 2023 Oct 27, 2023	SELL	$0.66 - $1.01 $7 - $12	-12 Reduced -0.0%	418,161 $275,000
Q2 2023 Aug 07, 2023	BUY	$0.82 - $1.19 $342,901 - $497,625	418,173 New	418,173 $393,000

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $32.1M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Acuitas Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuitas Investments, LLC with notifications on news.